Warning: This 1 TSX Stock Will Kill Your Portfolio: Sell Today!

It there is one finance article you read today, it should be this one. Here is the one company you should sell today due to major headwinds: Cineplex Inc. (TSX:CGX).

| More on:
Clock pointing towards a 'sell' signal

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Things are certainly not looking up for Canadian theatre company Cineplex Inc. (TSX:CGX). COVID-19-related shutdowns are significantly impairing this broad sector. Cineplex’s stock is now trading as a quasi-option on the survivability of the previously excellent cash flow generating machine.

In this article, I’m going to highlight a few reasons investors ought to avoid Cineplex stock altogether, despite its appeal as a deep value play.

Acquisition unlikely to go through

Anything is possible. But the planned Cineworld takeover of Cineplex for approximately $34 per share is now looking extremely unlikely. This stock has lost more than 3/4 of its value since the beginning of the year at the time of writing.

This current stock price implies little in the way of hope for the acquisition to go through, despite Cineplex’s best efforts. Cineplex has formally launched a lawsuit against Cineworld, saying that it believes Cineworld has breached contractual obligations to buy the company at its stated price.

Cineworld has responded that material changes have forced the U.K.-based cinema chain from completing the deal. This raises issues around whether the COVID-19 pandemic can be classified as a force majeur in this case.

While the lawyers battle this out (which won’t be cheap), analysts are also chiming in on Cineplex’s options for moving forward. Avoiding filing for bankruptcy protection is a priority for Cineplex. AMC Entertainment in the U.S. recently took the first steps to explore bankruptcy options — a move that took the whole sector broadly down.

Cineplex recently filed for a $275 million convertible debenture offering in a bid to shore up its balance sheet and provide extra liquidity in this time of uncertainty. A National Bank analyst has also indicated Cineplex may move to sell its headquarters building or other assets.

The company is trying to keep the lights on while COVID-related restrictions remain in place. These moves are positive from liquidity standpoint. On the other hand, these moves represent balance sheet deterioration. This is a negative for long term investors in this stock.

Long-term outlook bearish

I do think the long-term outlook for Cineplex has become far more bearish given these recent developments. Attracting high-risk populations back to movie theatres, even with social distancing measures in place, will be a difficult sell.

The secular shift away from movie theatres toward high-quality in-home entertainment options such as streaming platforms is likely to continue to eat away at already plummeting attendance numbers.

There really aren’t any bullish long-term catalysts I can think of for Cineplex right now. Surviving is one task on its own, and I don’t think survival is guaranteed for any player in this sector right now.

Growth is a whole other ball game, however. I think this sector has fundamentally shifted toward becoming non-investment grade, and as such, I believe the Foolish thing to do is to avoid this stock at all costs.

For those who own the stock, selling now and taking tax losses could be the most profitable decision long term.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »